Abstract
Plasmodium falciparum (Pf) is the predominant malaria species in Africa, but growing rates of non-falciparum species such as P. vivax (Pv) have been reported recently. This study aimed at characterizing drug resistance genes, glucose-6-phosphate dehydrogenase gene (G6PD), and phylogenetic patterns of a Pv + Pf co-infection misdiagnosed as a Pf mono-infection in the Far North region of Cameroon. Only one non-synonymous mutation in the pvdhps gene A383G was found. Pv drug resistance gene sequences were phylogenetically closer to the reference SAL-I strain and isolates from Southeast Asia and Western Pacific countries. Analyzing co-infecting Pf revealed no resistance mutations in Pfmdr1 and Pfk13 genes, but mutations in Pfcrt (C72V73I74E75T76) and Pfdhfr–Pfdhps genes (A16C50I51R59N108L164 – A436A437K540G581S613) were observed. No G6PD deficiency-related mutations were found. This is first study from Cameroon reporting presence of putative drug resistance mutations in Pv infections, especially in the pvdhps gene, and also outlined the absence of a G6PD-deficiency trait in patients.
Data Availability
The original contributions presented here are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.
Code Availability
Sequences generated are deposited to NCBI nucleotide database under Accession Numbers OR483860-OR483867, OR499100-OR499101 and OR503034.
Abbreviations
- ACT:
-
Artemisinin-based combination therapy
- AHA:
-
Acute hemolytic anemia
- CNSHA:
-
Chronic nonspherocytic hemolytic anemia
- DNA:
-
Deoxyribonucleic acid
- G6PD:
-
Glucose-6-phosphate dehydrogenase
- G6PD-d:
-
Glucose-6-phosphate dehydrogenase deficiency
- mt:
-
Mutant
- PCR:
-
Polymerase chain reaction
- Pf :
-
Plasmodium falciparum
- Pfcrt :
-
Plasmodium falciparum Chloroquine resistance transporter
- Pfdhfr :
-
Plasmodium falciparum Dihydrofolate reductase
- Pvdhps :
-
Plasmodium falciparum Dihydropteroate synthase
- Pfkelch13 :
-
Plasmodium falciparum Kelch protein 13
- Pfmdr-1 :
-
Plasmodium falciparum Multidrug resistance protein 1
- Pm :
-
Plasmodium malariae
- Po :
-
Plasmodium ovale
- PQ:
-
Primaquine
- Pv :
-
Plasmodium vivax
- Pvcrt :
-
Plasmodium vivax Chloroquine resistance transporter
- Pvdhfr :
-
Plasmodium vivax Dihydrofolate reductase
- Pvdhps :
-
Plasmodium vivax Dihydropteroate synthase
- Pvkelch12 :
-
Plasmodium vivax Kelch protein 12
- Pvmdr-1 :
-
Plasmodium vivax Multidrug resistance protein 1
- SEA:
-
South East Asia
- sSA:
-
Sub-Saharan Africa
- wt:
-
Wild type
- WHO:
-
World Health Organization
References
World Health Organization (2022) World malaria report 2022. WHO/HTM/GM. ISBN 978 92 4 1564403
Antonio-Nkondjio C, Ndo C, Njiokou F, Bigoga JD, Awono-Ambene P, Etang J, Ekobo AS, Wondji CS (2019) Review of malaria situation in Cameroon: technical viewpoint on challenges and prospects for disease elimination. Parasit Vectors 12:501. https://doi.org/10.1186/s13071-019-3753-8
Dongang Nana RR, Hawadak J, Kojom Foko LP, Kumar A, Chaudhry S, Arya A, Singh V (2023) Intermittent preventive treatment with sulfadoxine pyrimethamine for malaria: a global overview and challenges affecting optimal drug uptake in pregnant women. Pathog Glob Health 117:462–475. https://doi.org/10.1080/20477724.2022.2128563
Kojom Foko LP, Kouemo Motse FD, Kamgain Mawabo L, Pande V, Singh V (2021) First evidence of local circulation of Plasmodium ovale curtisi and reliability of a malaria rapid diagnostic test among febrile outpatients in Douala, Cameroon. Infect Genet Evol 91:104797. https://doi.org/10.1016/j.meegid.2021.104797
Kojom Foko LP, Hawadak J, Kouemo Motse FD, Eboumbou Moukoko EC, Kamgain Mawabo L, Pande V, Singh V (2022) Non-falciparum species and submicroscopic infections in three epidemiological malaria facets in Cameroon. BMC Infect Dis 22:900. https://doi.org/10.1186/s12879-022-07901-6
Kojom Foko LP, Arya A, Sharma A, Singh V (2021) Epidemiology and clinical outcomes of severe Plasmodium vivax malaria in India. J Infect 82:231–246. https://doi.org/10.1016/j.jinf.2021.03.028
Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ (2014) Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis 14:982–991. https://doi.org/10.1016/S1473-3099(14)70855-2
Kojom Foko LP, Kumar A, Hawadak J, Singh V (2023) Plasmodium cynomolgi in humans: current knowledge and future directions of an emerging zoonotic malaria parasite. Infection 51:623–640. https://doi.org/10.1007/s15010-022-01952-2
Luzzatto L, Ally M, Notaro R (2020) Glucose-6-phosphate dehydrogenase deficiency. Blood 136:1225–1240. https://doi.org/10.1182/blood.2019000944
Roman DNR, Rosalie NNA, Kumar A, Luther KMM, Singh V, Albert MS (2018) Asymptomatic Plasmodium malariae infections in children from suburban areas of Yaoundé, Cameroon. Parasitol Int 67:29–33. https://doi.org/10.1016/j.parint.2017.02.009
Nguiffo-Nguete D, Nongley Nkemngo F, Ndo C, Agbor JP, Boussougou-Sambe ST, Salako Djogbénou L, Ntoumi F, Adegnika AA, Borrmann S, Wondji CS (2023) Plasmodium malariae contributes to high levels of malaria transmission in a forest–savannah transition area in Cameroon. Parasit Vectors 16:31. https://doi.org/10.1186/s13071-022-05635-7
Djeunang Dongho GB, Gunalan K, L’Episcopia M et al (2021) Plasmodium vivax infections detected in a large number of febrile Duffy-negative Africans in Dschang, Cameroon. Am J Trop Med Hyg 104:987–992. https://doi.org/10.4269/ajtmh.20-1255
Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN (1993) Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 58:283–292. https://doi.org/10.1016/0166-6851(93)90050-8
Fuehrer HP, Stadler MT, Buczolich K, Bloeschl I, Noedl H (2012) Two techniques for simultaneous identification of Plasmodium ovale curtisi and Plasmodium ovale wallikeri by use of the small-subunit rRNA gene. J Clin Microbiol 50:4100–4102. https://doi.org/10.1128/JCM.02180-12
Arya A, Kojom Foko LP, Chaudhry S, Sharma A, Singh V (2021) Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: a systematic review of clinical studies from two malaria endemic regions—India and sub-Saharan Africa. Int J Parasitol Drugs Drug Resist 15:43–56. https://doi.org/10.1016/j.ijpddr.2020.11.006
Kojom Foko LP, Narang G, Jakhan J, Tamang S, Moun A, Singh V (2023) Nationwide spatiotemporal drug resistance genetic profiling from over three decades in Indian Plasmodium falciparum and Plasmodium vivax isolates. Malar J 22:236. https://doi.org/10.1186/s12936-023-04651-x
Kumar S, Stecher G, Li M, Knyaz C, Tamura K (2018) MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 35:1547–1549. https://doi.org/10.1093/molbev/msy096
Luzzatto L, Nannelli C, Notaro R (2016) Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin N Am 30:373–393. https://doi.org/10.1016/j.hoc.2015.11.006
Oboh Aigbiremo M, Oyebola KM, Idowu ET, Badiane AS, Otubanjo OA, Ndiaye D (2020) Rising report of Plasmodium vivax in sub-Saharan Africa: implications for malaria elimination agenda. Sci Afr 10:e00596. https://doi.org/10.1016/j.sciaf.2020.e00596
Matlani M, Kojom LP, Mishra N, Dogra V, Singh V (2020) Severe vivax malaria trends in the last two years: a study from a tertiary care centre, Delhi, India. Ann Clin Microbiol Antimicrob 19:49. https://doi.org/10.1186/s12941-020-00393-9
Chaturvedi R, Chhibber-Goel J, Verma I, Gopinathan S, Parvez S, Sharma A (2021) Geographical spread and structural basis of sulfadoxine-pyrimethamine drug-resistant malaria parasites. Int J Parasitol 51:505–525. https://doi.org/10.1016/j.ijpara.2020.12.011
Benavente ED, Manko E, Phelan J et al (2021) Distinctive genetic structure and selection patterns in Plasmodium vivax from South Asia and East Africa. Nat Commun 12:3160. https://doi.org/10.1038/s41467-021-23422-3
Jin X, Zhu S, Xu W, Chen J, Ruan W, Wang X (2021) Limited polymorphism in k13 gene of Plasmodium falciparum and k12 of Plasmodium vivax isolates imported from African and Asian countries between 2014 and 2019 in Hangzhou city, China. BMC Infect Dis 21:853. https://doi.org/10.1186/s12879-021-06579-6
Wang M, Siddiqui FA, Fan Q, Luo E, Cao Y, Cui L (2016) Limited genetic diversity in the PvK12 Kelch protein in Plasmodium vivax isolates from Southeast Asia. Malar J 15:537. https://doi.org/10.1186/s12936-016-1583-0
Niba PTN, Nji AM, Evehe MS et al (2021) Drug resistance markers within an evolving efficacy of anti-malarial drugs in Cameroon: a systematic review and meta-analysis (1998–2020). Malar J 20:32. https://doi.org/10.1186/s12936-020-03543-8
Uwimana A, Legrand E, Stokes BH et al (2020) Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med 26:1602–1608. https://doi.org/10.1038/s41591-020-1005-2
Balikagala B, Fukuda N, Ikeda M et al (2021) Evidence of artemisinin-resistant malaria in Africa. N Engl J Med 385:1163–1171. https://doi.org/10.1056/NEJMoa2101746
Chauvin P, Menard S, Iriart X, Nsango SE, Tchioffo MT, Abate L, Awono-Ambéné PH, Morlais I, Berry A (2015) Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles. J Antimicrob Chemother 70:2566–2571. https://doi.org/10.1093/jac/dkv160
Mbanefo EC, Ahmed AM, Titouna A et al (2017) Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis. Sci Rep 7:45963. https://doi.org/10.1038/srep45963
Lauden SM, Chongwain S, Achidi A, Helm E, Cusick SE, Krug A, Slusher TM, Lund TC (2019) Prevalence of glucose-6-phosphate dehydrogenase deficiency in Cameroonian blood donors. BMC Res Notes 12:195. https://doi.org/10.1186/s13104-019-4226-z
Awah F, Uzoegwu P (2008) Malaria protection in glucose-6-phosphate dehydrogenase deficient individuals in Bamenda population of Cameroon. Glob J Pure Appl Sci 14:343–347. https://doi.org/10.4314/gjpas.v14i3.16819
Bernstein SC, Bowman JE, Noche Kaptue L (1980) Interaction of sickle cell trait and glucose-6-phosphate dehydrogenase deficiency in Cameroon. Hum Hered 30:7–11. https://doi.org/10.1159/000153080
Bernstein SC, Bowman JE, Noche Kaptue L (1980) Population studies in Cameroon: hemoglobin S, glucose-6-phosphate dehydrogenase deficiency and falciparum malaria. Hum Hered 30:251–258. https://doi.org/10.1159/000153138
Sobngwi E, Gautier JF, Kevorkian JP, Villette JM, Riveline JP, Zhang S, Vexiau P, Leal SM, Vaisse C, Mauvais-Jarvis F (2005) High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes. J Clin Endocrinol Metab 90:4446–4451. https://doi.org/10.1210/jc.2004-2545
Acknowledgements
The authors are grateful to patients who accepted to take part in the study, and Dr MALAMA Toussaint, Dr GANAVA Maurice and Mr. NINSU Cedric for help in collecting samples in North and Far North regions. Special thanks to Dr John O. Oladokun, PhD (Postdoctoral Extension Research Associate, Texas A&M University, Texas, USA) for his comments on English language editing and proofreading.
Funding
The authors are grateful to Department of Biotechnology (DBT), New Delhi, India; The World Academy of Sciences (TWAS), Trieste, Italy; and ICMR–National Institute of Malaria Research, New Delhi, India, for the fellowship (DBT–TWAS Postgraduate Fellowship Programme – 2017, N° 3240300010) jointly awarded to Dr. Loick P. Kojom Foko.
Author information
Authors and Affiliations
Contributions
LPKF and VS conceived and designed the study. LPKF performed laboratory experiments, analyzed data and drafted the first version of the manuscript. JJ and ST helped in laboratory experiments and performed sequencing. JH and FDKM helped in sample collection. JH created the map used in the study. JH, JJ, ST, FDKM and VS helped in data interpretation and revised the manuscript for important intellectual content. VS supervised the work at all stages. All authors read and approved the final paper.
Corresponding author
Ethics declarations
Competing Interests
The authors have no relevant financial or non-financial interests to disclose.
Ethical Approval
Approvals were sought from ethical committee of Delegation of Public Health in Littoral, North, and Far North regions, Ministry of Public Health, Cameroon (No 2596/AS/MINSANTE/DRSPL/BCASS, N° 1623/MINSANTE/DRSPN/PNLP/CR, and 0887/MINSANTE/DRSPEN/CR/PNLP/CR) to collect samples in each health facility (Pette district hospital, Mayo-Oulo district hospital, Laboratoire Sainte Thérèse, and Maroua District hospital). The study was also approved by institutional ethics committee of ICMR-NIMR, New Delhi, India (N° PHB/NIMR/EC/2020/55). All patients signed an informed consent form and in case of minors it was signed by a parent and/or legal guardian for study participation. All methods were carried out in accordance with relevant guidelines and regulations.
Consent to Participate
Informed consent was obtained from all individual participants included in the study. For children and minors, informed consent was obtained from parents or legal guardians.
Consent for Publication
The participant has consented to the submission of the short communication to the journal.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kojom Foko, L.P., Jakhan, J., Tamang, S. et al. First Insight into Drug Resistance Genetic Markers, Glucose-6-Phosphate Dehydrogenase and Phylogenetic Patterns of Misdiagnosed Plasmodium vivax Malaria in Far North Region, Cameroon. Curr Microbiol 81, 9 (2024). https://doi.org/10.1007/s00284-023-03522-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00284-023-03522-7